Streetbeat News

Stock Prices

OPRA

Opera shares rise as B. Riley Securities maintains a Buy rating and increases the price target from $22 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:47 pm

ADI

Wealthy investors have taken a bearish stance on Analog Devices (NASDAQ:ADI) through options trading, with 53% of trades being bearish. The significant options activity suggests a price range of $200 to $240 for ADI in the coming months. The stock is currently up 2.41% at $227.26, but RSI indicators suggest it may be overbought.

Portfolio Pulse from Benzinga Insights

August 23, 2024 | 3:47 pm

AMAT

Applied Materials (NASDAQ:AMAT) has seen a surge in options activity, with a mix of bullish and bearish trades. Significant investors are targeting a price range of $110 to $220. Analysts have mixed ratings, with price targets ranging from $224 to $280.

Portfolio Pulse from Benzinga Insights

August 23, 2024 | 3:47 pm

ZM

Zoom Video Communications shares rose as Deutsche Bank maintained a Hold rating and increased its price target from $71 to $75.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:46 pm

LIND

Lindblad Expeditions' stock price increased following B. Riley Securities' decision to maintain a Buy rating and raise the price target from $15 to $16.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:45 pm

SPRY

ARS Pharmaceuticals' Neffy, a needle-free nasal spray for allergic reactions, has been FDA approved. It offers convenience over traditional EpiPens but faces skepticism regarding real-world efficacy. Neffy is easier to carry and has a longer shelf life, but concerns about insurance coverage and effectiveness during actual emergencies remain.

Portfolio Pulse from Vandana Singh

August 23, 2024 | 3:43 pm

INTC

MRVL

TSM

Semiconductor stocks are experiencing a rise in share prices due to positive market sentiment following comments from Fed Chair Powell regarding the economy and potential future rate cuts.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:42 pm

WOK

WORK Medical Technology shares have resumed trading after a temporary halt. The resumption of trade could indicate a resolution of any issues that led to the halt, potentially impacting investor sentiment and stock price.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:41 pm

WORK

WORK Medical Technology shares were halted due to a circuit breaker triggered by a significant upward price movement.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:38 pm

WORK

WORK Medical Technology's shares began trading at $3.60 per share, below the IPO price of $4 per share for 2 million shares.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 3:37 pm